Posted in | News | Uranium | Mining Business

GoviEx Uranium Announces Filing of ESIA Report for Madaouela Project

GoviEx Uranium Inc. announced today that the Environmental and Social Impact Assessment (ESIA) for the company's Madaouela Uranium Project has been completed and filed with the Nigerien Minister in charge of the Environment.

Subject to the successful acceptance of the ESIA, the company expects that the environmental certificate for the Madaouela Project could be issued as early as Q'2 2015, which would position the company to file an application for a Mining Permit in early Q'3 2015.

"This marks a significant milestone towards GoviEx's goal of developing Madaouela into a large, low-cost uranium mine in the prolific Arlit uranium-mining district of northern Niger," said Daniel Major, GoviEx's Chief Executive Officer. "The ESIA highlights our ongoing efforts to meet or exceed international best practices in the advancement of the Madaouela Project.

"We remain confident that we can complete the mine permitting process as outlined in the Niger Mining Code by the end of 2015, thereby positioning the company to benefit from an improving uranium market."

The Madaouela Development Plan, as set out in the company's NI 43-101 Integrated Development Plan, defined a large, low operating cost, commercially viable uranium project in northern Niger, containing probable mineral reserves of approximately 55 million pounds (Mlb) U3O8.1 Niger, which produces between 7% and 8% of global uranium supply, has produced more than 120,000 tonnes of U3O8 over the past 40 years, making it the world's fourth largest uranium producing country.

Highlights of GoviEx's Madaouela Uranium Project:

  • Madaouela contains 98 Mlb U3O8 in Measured and Indicated Resources and 24 Mlb U3O8 in Inferred Resources.2
  • Majority of the more than 600,000 metres drilling completed by GoviEx has been focused on only one of five licences, so there remains considerable exploration upside potential.
  • NI 43-101 pre-feasibility study was based on quoted costs, indicates an initial 18-year mine life with 46 Mlb U3O8 produced at a cash cost of $26/lb U3O8.3
  • Madaouela is 15 kilometres from Areva's operating mines of Somair and Cominak. The local town of Arlit has a population of 160,000. Road and electrical power lines cross the GoviEx exploration tenements, and conservative estimates suggest sufficient process water is available.

The company now is optimizing the Madaouela Development Plan in order to assess the potential benefits of a number of technical changes to the processing design, which are expected to reduce sulphuric acid consumption and operating costs, and potentially increase probable mineral reserves.

1,2, 3 As reported in NI 43-101 An Updated Integrated Development Plan for the Madaouela Project, Niger, effective September 20, 2013 and amended April 28, 2014.

Qualified Person

The scientific and technical information in this release has been reviewed and approved by Dr. Rob Bowell, a chartered chemist of the Royal Society of chemistry, a chartered geologist of the Geological Society of London and Fellow of the Institute of Mining, Metallurgy and Materials who is an independent Qualified Person under the terms of National Instrument 43-101 for uranium deposits. For detailed information about assay methods and data verification measures used to support the scientific and technical information, please refer to the current technical report on the Madaouela Project on the SEDAR profile of GoviEx Uranium at www.sedar.com.

About GoviEx Uranium Inc.

GoviEx is a CSE-listed mineral resource company incorporated in British Columbia. The company's principal objective is to become a significant uranium producer through the continued exploration and development of its Madaouela Project and its other uranium properties in Niger. Toshiba Corporation and Cameco Corporation are major shareholders of GoviEx.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.